0.889
price up icon0.84%   0.0074
after-market アフターアワーズ: .85 -0.039 -4.39%
loading
前日終値:
$0.8816
開ける:
$0.9
24時間の取引高:
56,822
Relative Volume:
0.24
時価総額:
$4.60M
収益:
-
当期純損益:
$-6.78M
株価収益率:
-0.0208
EPS:
-42.6996
ネットキャッシュフロー:
$-4.67M
1週間 パフォーマンス:
+0.28%
1か月 パフォーマンス:
-8.35%
6か月 パフォーマンス:
-40.73%
1年 パフォーマンス:
-33.66%
1日の値動き範囲:
Value
$0.8512
$0.90
1週間の範囲:
Value
$0.8301
$0.9328
52週間の値動き範囲:
Value
$0.80
$2.30

Clearmind Medicine Inc Stock (CMND) Company Profile

Name
名前
Clearmind Medicine Inc
Name
セクター
Healthcare (1174)
Name
電話
-
Name
住所
-
Name
職員
1
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
CMND's Discussions on Twitter

CMND を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CMND
Clearmind Medicine Inc
0.889 4.60M 0 -6.78M -4.67M -42.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Clearmind Medicine Inc (CMND) 最新ニュース

pulisher
Jun 16, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Jun 16, 2025
pulisher
Jun 16, 2025

Clearmind Medicine Inc. (NASDAQ:CMND) Short Interest Update - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces Granting of Stock and Warrants - Psychedelic Alpha

Jun 13, 2025
pulisher
Jun 12, 2025

Clearmind Medicine Inc. (NASDAQ:CMND) Shares Acquired by Citadel Advisors LLC - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

# Clearmind Medicine hires lobbying firm to advance psychedelic therapy By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

# Clearmind Medicine hires lobbying firm to advance psychedelic therapy - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics - The Manila Times

Jun 12, 2025
pulisher
Jun 12, 2025

Clearmind Medicine Partners with Leading Government Affairs Firm to Advance Psychedelic Therapeutics - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic ... - Bluefield Daily Telegraph

Jun 12, 2025
pulisher
Jun 05, 2025

Clearmind Medicine Announces Enrollment Of First Patient In Phase I/Iia Clinical Trial For Alcohol Use Disorder Treatment - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment - The Manila Times

Jun 05, 2025
pulisher
Jun 05, 2025

Clearmind Medicine Inc. Begins Phase I/IIa Trial for CMND-100 to Treat Alcohol Use Disorder - Nasdaq

Jun 05, 2025
pulisher
May 30, 2025

symbol__ Stock Quote Price and Forecast - CNN

May 30, 2025
pulisher
May 20, 2025

Longeveron® to Attend BIO International Convention 2025 - TradingView

May 20, 2025
pulisher
May 12, 2025

SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

SciSparc Ltd. Announces European Patent Application for Cocaine Addiction Treatment in Collaboration with Clearmind Medicine Inc. - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction - The Manila Times

May 12, 2025
pulisher
May 12, 2025

SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction - The Manila Times

May 12, 2025
pulisher
May 05, 2025

Stocks Under $1 To Watch: $NITO, $SPRC, $PNPNF, $NCNA, $PRSO – Multi-Sectors Momentum Building more inside… | FinancialContent - FinancialContent

May 05, 2025
pulisher
Apr 28, 2025

Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder | DelveInsight - GlobeNewswire Inc.

Apr 28, 2025
pulisher
Apr 25, 2025

Clearmind Medicine files patent for eating disorder treatment - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind file patent for eating disorder treatment - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

Clearmind Medicine files patent for eating disorder treatment By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind file patent for eating disorder treatment By Investing.com - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

Psychedelic: Clearmind completes clinical site initiations for AUD trial - Yahoo Finance

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc and Clearmind File Patent for Eating Disorder Treatment - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire

Apr 25, 2025
pulisher
Apr 25, 2025

Clearmind Medicine Inc. Files International Patent for Novel Treatment of Eating Disorders Using 3-MMC and PEA - Nasdaq

Apr 25, 2025
pulisher
Apr 25, 2025

Novel Eating Disorder Treatment Patent Filed for 70M Patient Market | SPRC Stock News - Stock Titan

Apr 25, 2025
pulisher
Apr 23, 2025

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

Clearmind Medicine Inc. Initiates Patient Enrollment for Phase I/IIa Clinical Trial in Alcohol Use Disorder - Nasdaq

Apr 23, 2025
pulisher
Apr 23, 2025

Clearmind Medicine (NASDAQ:CMND) Stock Price Down 4.8% – Here’s Why - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

Clearmind Medicine Inc (CMND) requires closer examination - uspostnews.com

Apr 22, 2025
pulisher
Apr 21, 2025

Clearmind Medicine Inc Inc. (CMND) Price Performance and Its Relation to the Tech Industry - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts - TradingView

Apr 21, 2025
pulisher
Apr 21, 2025

Clearmind Medicine to Host Live Webinar 'Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts - The Manila Times

Apr 21, 2025
pulisher
Apr 21, 2025

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading - Bluefield Daily Telegraph

Apr 21, 2025
pulisher
Apr 17, 2025

Clearmind Medicine Receives Notice Of Allowance For United States Patent Covering Binge Behavior - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior - TradingView

Apr 17, 2025
pulisher
Apr 16, 2025

Clearmind Medicine Launches First U.S. Clinical Site For FDA-Approved Alcohol Use Disorder Trial - Nasdaq

Apr 16, 2025
pulisher
Apr 16, 2025

Clearmind Medicine begins phase I/IIa trial for AUD treatment - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism - The Manila Times

Apr 16, 2025
pulisher
Apr 16, 2025

Clearmind Medicine Inc. Initiates Phase I/IIa Clinical Trial for CMND-100 in Alcohol Use Disorder at Johns Hopkins University - Nasdaq

Apr 16, 2025
pulisher
Apr 16, 2025

Clearmind Medicine Launches First U.S. Clinical Site For Its FDA-Approved Clinical Trial To Combat Alcoholism - MarketScreener

Apr 16, 2025
pulisher
Apr 11, 2025

Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial - Yahoo Finance

Apr 11, 2025
pulisher
Apr 11, 2025

Clearmind Medicine (CMND) Launches U.S. Clinical Trial for Alcoh - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder - The Manila Times

Apr 10, 2025
pulisher
Apr 08, 2025

Clearmind Medicine files patent for new psychedelic compounds - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders - The Manila Times

Apr 08, 2025
pulisher
Apr 07, 2025

Clearmind Medicine stock hits 52-week low at $0.95 By Investing.com - Investing.com South Africa

Apr 07, 2025

Clearmind Medicine Inc (CMND) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):